Correlation Between Kandi Technologies and Titan Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kandi Technologies and Titan Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kandi Technologies and Titan Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kandi Technologies Group and Titan Pharmaceuticals, you can compare the effects of market volatilities on Kandi Technologies and Titan Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kandi Technologies with a short position of Titan Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kandi Technologies and Titan Pharmaceuticals.
Diversification Opportunities for Kandi Technologies and Titan Pharmaceuticals
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kandi and Titan is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Kandi Technologies Group and Titan Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Titan Pharmaceuticals and Kandi Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kandi Technologies Group are associated (or correlated) with Titan Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Titan Pharmaceuticals has no effect on the direction of Kandi Technologies i.e., Kandi Technologies and Titan Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kandi Technologies and Titan Pharmaceuticals
Given the investment horizon of 90 days Kandi Technologies is expected to generate 1.19 times less return on investment than Titan Pharmaceuticals. But when comparing it to its historical volatility, Kandi Technologies Group is 2.13 times less risky than Titan Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Titan Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,396 in Titan Pharmaceuticals on January 20, 2024 and sell it today you would lose (664.00) from holding Titan Pharmaceuticals or give up 47.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.8% |
Values | Daily Returns |
Kandi Technologies Group vs. Titan Pharmaceuticals
Performance |
Timeline |
Kandi Technologies |
Titan Pharmaceuticals |
Kandi Technologies and Titan Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kandi Technologies and Titan Pharmaceuticals
The main advantage of trading using opposite Kandi Technologies and Titan Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kandi Technologies position performs unexpectedly, Titan Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan Pharmaceuticals will offset losses from the drop in Titan Pharmaceuticals' long position.Kandi Technologies vs. Microvast Holdings | Kandi Technologies vs. EVgo Equity Warrants | Kandi Technologies vs. Xos Inc | Kandi Technologies vs. AEye Inc |
Titan Pharmaceuticals vs. Alkermes Plc | Titan Pharmaceuticals vs. Ironwood Pharmaceuticals | Titan Pharmaceuticals vs. Deciphera Pharmaceuticals LLC | Titan Pharmaceuticals vs. Eagle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |